Copyright: ©Author(s) 2026.
World J Gastroenterol. Nov 28, 2026; 32(44): 121025
Published online Nov 28, 2026. doi: 10.3748/wjg.121025
Published online Nov 28, 2026. doi: 10.3748/wjg.121025
Figure 3 Knockdown of Fascin actin-bundling protein-1 inhibits M2 phenotype of macrophages.
A-C: The mRNA expression levels of M1 markers NOS2, tumor necrosis factor-α, and interleukin-1β; D-F: The mRNA expression levels of M2 markers arginase 1, CD206, and interleukin-10; G and H: Immunofluorescence staining of M1 marker CD86 and M2 marker CD163. Scale bar = 50 μm. cP < 0.001. THP-1 cells were induced to differentiate into macrophages by PMA and treated with conditioned medium containing SW620, SW620-si-NC, and SW620-si-FSCN1 cells, respectively. TNF-α: Tumor necrosis factor-α; FSCN1: Fascin actin-bundling protein-1; CM: Conditioned medium; Arg1: Arginase 1; IL: Interleukin; NC: Non-targeting control.
- Citation: Wang Z, Liu C, Liu H, Jiang Y, Ma Y. FSCN1/ACK1 axis-dependent M2 macrophage polarization fuels colorectal cancer progression. World J Gastroenterol 2026; 32(44): 121025
- URL: https://www.wjgnet.com/1007-9327/full/v32/i44/121025.htm
- DOI: https://dx.doi.org/10.3748/wjg.121025